Navigation Links
Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries
Date:4/16/2008

Industry supports hundreds of programs helping millions in the developing world and is looking for new partners

WASHINGTON, April 16 /PRNewswire-USNewswire/ -- The worldwide pharmaceutical industry today launched Global Health Progress, an initiative to bring research-based biopharmaceutical companies, global health leaders and policymakers together to build on current partnerships to improve health in the developing world.

Serving as a convening point for the industry and its partners, Global Health Progress will facilitate interaction between the private sector, NGOs and governments to share research and best practices; raise awareness of global health challenges; and build partnerships to improve global health.

"Research-based biopharmaceutical companies contribute hugely to health partnerships for the developing world, through their unique expertise in R&D, regulatory affairs, manufacturing, logistics and many other fields, but we can't work alone," said Dr. Harvey Bale, Director General of IFPMA. "The Global Health Progress initiative should help to expand the range and scope of global health partnerships supported by our industry."

Global Health Progress today unveiled its web site, http://www.globalhealthprogress.org, which houses a database of research-based biopharmaceutical companies' global health programs, including information on more than 300 partners, 400 programs and ongoing investments of billions of dollars annually in products and man-hours. Featuring stories of health workers on the ground, the site highlights organizations and individuals who are making a difference in global health.

"Research-based biopharmaceutical companies have a longstanding commitment to improving global health - this initiative is a recognition of our unique role and desire to accelerate progress in fighting disease and strengthening health care systems in d
'/>"/>

SOURCE Global Health Progress
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
2. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
3. Global Med Technologies(R) Extends Its Worldwide Outreach
4. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
5. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
6. New USAID grant helps Georgetown meet unmet family planning needs worldwide
7. The Cardiovascular Multimedia Network (CVMD) and the International Society of Endovascular Specialists (ISES) Join Forces to Educate Practitioners Worldwide Through Electronic Media
8. Unilens Names Eschenbach Optik Exclusive Worldwide Distributor of the UniVision(R) Low Vision Lens
9. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
10. Allscripts Featured in Microsoft HealthVault Worldwide Launch
11. Abortion Numbers Fall Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...n (a) levels boost cardiovascular disease risk fo...y News) -- If you,re worried about reducing your r...at you should quit smoking, eat a healthful diet, ...eck, and make sure your cholesterol levels aren,t ...ein (a) levels are? , Well, if you don,t have ...
(Date:10/10/2008)...mpany committed to helping people address health n.../ -- In these troubling,economic times, people may... may feel that they don,t have the money to visit ...a survey by the National Association of,Insurance ... -- Twenty-two percent of Americans say that they ...
(Date:10/10/2008)...Oct. 10 /PRNewswire/ -- Do you think that the blin...d town? Attend the October,17 open house at the Vi...ion Impaired, and see how instructors there empowe...ve, fulfilling lives through non-visual,techniques...1 Azalea Avenue, is holding an open house to,celeb...
(Date:10/10/2008)...omy serving as tipping point for behavior change, ...-- More than half of,Americans (51 percent) believ...are system, but major changes are needed, accordin...urvey was released today by the,Employee Benefit R...tes,Inc., and was underwritten by the Principal Fi...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Healthcare Resources Available in Difficult Times 2Health News:Healthcare Resources Available in Difficult Times 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3
...search has proved that a new drug named histatin, ...ills the fungus- Candida albicans,// which is resp...s known that candidiasis, also known as thrush, is...ts and ulcers on the membranes of the mouth, tongu...
...udies on vitamin E seemed to suggest that suppleme...cancer and heart problems. //Recently, a study pub... says the reality of taking vitamin E supplements ...searchers had studied patients with cardiovascular...
...ur kind of immunity may lead you to blindness. Acc...ience journal, //scientists had been able to find ...ight. In search of what is commonly known as blin... up with a gene that may cause macular degeneratio...
... has been shown that the drug Rimonabant (Acompli... can help obese patients keep weight off // . Supp... resulted in a significant decrease in body weight...cularly dangerous visceral fat. It also improved H...
Other Medicine News:
(Date:10/7/2008)...wire/ -- Prometheus Laboratories Inc., a,specialty...from its,development of PROMETHEUS(R) IBS Diagnost...wel syndrome (IBS). The findings suggest measurabl...arkers in blood samples,between IBS and non-IBS pa...mbined with a proprietary algorithm, led to the de...
(Date:10/7/2008)...Newswire/ -- The Texas Cardiac Arrhythmia,Institut...lected as one of,only a few sites in the nation to... a new device to treat persistent atrial fibrillat...d research center specializing in heart,rhythm dis...al Center and,Texas Cardiovascular Consultants., ...
(Date:10/7/2008)...tate Prevented Immunologic Changes Induced by ..., Additional Data Indicates Potential in Treating ... /- Alba Therapeutics Corporation,pre... at the American,College of Gastroenterology (ACG)...LIN 1001-004, the first Phase IIa trial conducted ...
(Date:10/7/2008)... 7 /- A study published in the,scient...self-renewal,reported that InVitria,s ( http://ww...m albumin) was an effective replacement to bovine ...titled, "The ground state of embryonic stem cell,s...astim as a recombinant,albumin in place of animal-...
Breaking Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Male Partner Violence Hurts Womens Health Worldwide 15952 1Male Partner Violence Hurts Womens Health Worldwide 15952 2Study Finds Mass Media Campaigns Alone Can Effectively Reduce High Risk Sexual Behavior Among Impulsive Sensation Seeking Young Adults 15950 1Study Finds Mass Media Campaigns Alone Can Effectively Reduce High Risk Sexual Behavior Among Impulsive Sensation Seeking Young Adults 15950 2Study Finds Mass Media Campaigns Alone Can Effectively Reduce High Risk Sexual Behavior Among Impulsive Sensation Seeking Young Adults 15950 3PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 15948 1PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 15948 2IPC The Hospitalist Company Added to Russell 2000 Index 15946 1IPC The Hospitalist Company Added to Russell 2000 Index 15946 2
...o., March 06, 2007 /PRNewswire-FirstCall/ --,Repli...ts Phase II,clinical trial using faropenem medoxom...itis media (AOM), a common infection of the,middle...hat it met,its primary objective to show that faro...the middle ear and to permit the dose,selection fo...
...., March 06, 2007 /PRNewswire-FirstCall/ --,Advanc...completed,Phase III multi- center clinical studies... therapeutic will be presented during,the National...ings,taking place April 10th through 14th in Orlan...cheduled to be presented on,Wednesday, April 11, 2...
Other Medicine Technology:Replidyne Phase II Pediatric Trial Meets Primary Objective 2Replidyne Phase II Pediatric Trial Meets Primary Objective 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 4
Portable shields for your safety and convenience.
Full-Height Radiation Barriers provide full-body shielding and reduce eye strain during extended procedures.
0.5 mm Pb protection with height-adjustment for patient and practitioner. Measures 18"L x 24"W adjusts 36" to 56" in height at lowest height (36") bottom hem remains 12" from floor. 5 leg base for ma
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre
Medicine Products: